mTORC1-Plin3 pathway is essential to activate lipophagy and protects against hepatosteatosis.
M. Garcia-Macia, A. Santos-Ledo, J. Leslie, H. Paish, A. Watson, L. Borthwick, J. Mann, F. Oakley, V. I. Korolchuk, D. A. Mann
Abstract
During postprandial state, the liver is exposed to high levels of dietary fatty acids (FAs) and carbohydrates. FAs are re-esterified into triglycerides, which can be stored in lipid droplets (LDs) in the liver. Aberrant accumulation of LDs can lead to diseases such as alcoholic liver disease and non-alcoholic fatty liver disease, the latter being the most common liver pathology in western countries. Improved understanding of LD biology has potential to unlock new treatments for these liver diseases. The Perilipin (Plin) family is the group of proteins that coat LDs, controlling their biogenesis, stabilization, and preventing their degradation. Recent studies have revealed that autophagy is involved in LD degradation and, therefore, may be crucial to avoid lipid accumulation. Here, we show that a phosphorylated form of Plin3 is required for selective degradation of LDs in fibroblasts, primary hepatocytes and human liver slices. We demonstrate that oleic acid treatment induces the recruitment of the autophagy machinery to the surface of LDs. When Plin3 is silenced, this recruitment is suppressed resulting in accumulation of lipid. Plin3 pulldowns revealed interactions with the autophagy initiator proteins Fip200 and Atg16L indicating that Plin3 may function as a docking protein involved in lipophagy activation. Of particular importance, we define Plin3 as a substrate for mTORC1-dependent phosphorylation and show that this event is decisive for lipophagy. Our study therefore reveals that Plin3, and its phosphorylation by mTORC1, is crucial for degradation of LDs by autophagy. We propose that stimulating this pathway to enhance LD autophagy in hepatocytes will help protect the liver from lipid-mediated toxicity thus offering new therapeutic opportunities in human steatotic liver diseases.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PNPLA3(148M) Promotes Hepatic Steatosis by Interfering with Triglyceride Hydrolysis Through a Gain-of-Function Mechanism
Yang Wang, Sen Hong, … Helen H. Hobbs·Journal of HepatologyPeer-reviewed·Nov 14, 2024
- Liver lipophagy ameliorates nonalcoholic steatohepatitis through lysosomal lipid exocytosis
Y. Minami, A. Hoshino, … S. Matoba·bioRxiv·Feb 22, 2022
- RAB18 confers protection to lipid droplets from lysolipophagy and counters cellular steatosis
A. Rieck, G. Guenther, … N. Vartak·bioRxiv·Mar 11, 2023
- Functional interaction of torsinA and its activators in liver lipid metabolism
A. Hernandez-Ono, Y. P. Zhao, … J.-Y. Shin·bioRxiv·Jun 21, 2023
- MTARC1 Regulates Lipid Droplet Degradation via Phospholipid Remodeling in Metabolic Fatty Liver Disease
- Spatially resolved rewiring of mitochondria-lipid droplet interactions in hepatic lipid homeostasis
Sun Woo Sophie Kang, Lauryn A. Brown, … Natalie Porat‐Shliom·Nature MetabolismPeer-reviewed·Mar 23, 2026